D

DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE (Private limited company)

DR. S. PRIVALENKO
BE 0817.283.495 Active ●Brusselstraat 51, 2018 Antwerpen (seat struck off on 11/01/2026)

DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0817.283.495. It was founded on 17-07-2009. Its main activity is: Human health activities. Its annual accounts for 2025 report equity of € 292 427 and a loss of € 35 508. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 2 of its last 4 financial years.

Information last updated on 20-10-2026.

Company information

Status
Active
Enterprise number
BE 0817.283.495
VAT registered
No
Founded
17-07-2009
Latest accounts
2025
Employees
-
Region
-
Establishments
1
Filing record
On time 2 of 4 years
Peppol e-invoicing
Not registered
Registered office
Brusselstraat 51, 2018 Antwerpen
Seat struck off on 11/01/2026
Main activity
Human health activities
NACE activities
86210 Activités de médecine générale

Key figures of DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -35 508€ 19 867-76 %€ 81 975+51 %€ 54 362
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 292 427-11 %€ 327 935+193 %€ 111 882-51 %€ 226 094
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 359 649-22 %€ 462 318+6 %€ 436 501+46 %€ 299 544
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -250€ 54 550-62 %€ 143 509+47 %€ 97 771
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade E, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
3 mandates on record in the annual accounts. 1 of them started since 2024.
Create a free account

Similar companies

No other company with the same activity is listed near this one yet.

Looking for more information about DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE still active? Yes. The Crossroads Bank for Enterprises lists DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE as active.

What is the VAT number of DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE? DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE is not registered for VAT. Its enterprise number is 0817.283.495.

When was DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE founded? DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE was founded on 17-07-2009.

What is the address of DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE? The register struck off the registered office of DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE (Brusselstraat 51, 2018 Antwerpen) on 11/01/2026 and records no current seat.

When did DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE last file annual accounts? The latest annual accounts of DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE were filed on 17-08-2026.

Does DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE file its annual accounts on time? DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE filed its annual accounts within the legal deadline for 2 of its last 4 financial years. Late: 2022, 2024.

Is DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE financially healthy? Addrly gives DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE profitable? The annual accounts of DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE for 2025 show a loss of € 35 508.

What is the equity of DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE? The equity of DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE was € 292 427 at the close of the 2025 financial year.

Who are the directors of DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE? The annual accounts of DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE record 3 mandates. The names, roles and dates are visible with a free account.

Can DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE receive Peppol e-invoices? DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE is not registered on the Peppol network at the moment.

What does DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE do? The main activity of DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE is: Human health activities.

Sources

How Addrly builds and refreshes this data